Grifols: the board considers that Brookfield’s indicative price undervalues the company Teva: S&P upgrades the rating to BB/positive from BB/positiveElior: Results recovered in 2023-24, exceeding expectations. Debt reduction is making headway as planned.Tereos: Sharp decline in EBITDA in Q2 24/25. The financial position is stable thanks to the generation of FCF.>...
Grifols : le conseil d’administration estime que le prix indicatif proposé par Brookfield sous-évalue la sociétéTeva: S&P upgrades the rating to BB/positive from BB/positiveElior: les résultats se sont redressés 2023/24, dépassant les attentes. Le désendettement progresse comme prévu.Tereos : fort repli de l'EBITDA au T2 24/25. La situation financière est stable grâce à la génération de FCF.>...
A director at Bayer AG bought 11,278 shares at 20.745EUR and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
>Q3 results in line with preliminary figures - This morning, Hapag-Lloyd published its Q3 results. There were no major surprises in the figures which were fully in line with the preliminary data published three weeks ago. As such, group revenue over the quarter was € 5.26bn, up 28% y-o-y thanks to a favourable price environment (freight rate up 23% y-o-y) and a 3.8% y-o-y increase in volumes (in line with what we have seen since the beginning of the year). Profitabili...
>Des résultats T3 en ligne avec les chiffres préliminaires - Hapag-Lloyd publie ce matin ses résultats du T3. Les chiffres ressortent sans grandes surprises, parfaitement en ligne avec les données préliminaires publiées il y a trois semaines. Ainsi, les revenus groupe sur le trimestre atteignent 5.26 Md€, soit une progression de 28% yoy profitant d’un environnement de prix favorable (taux de fret en croissance de 23% yoy) et des volumes en hausse de 3.8% yoy (dans la ...
EQS-News: Hapag-Lloyd AG / Schlagwort(e): 9-Monatszahlen Hapag-Lloyd mit gutem Ergebnis nach drei Quartalen 2024 14.11.2024 / 07:29 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Hapag-Lloyd mit gutem Ergebnis nach drei Quartalen 2024 Transportmenge gegenüber Vorjahr gesteigert Stärkere Nachfrage und gestiegene Frachtraten, insbesondere im dritten Quartal Ergebnisprognose im Oktober angehoben Strategie 2030: Wachstum und Qualität bleiben im Fokus Hapag-Lloyd hat die ersten neun Monate 2024 mit einem Konzern-EBITDA von 3,6 Milliar...
EQS-News: Hapag-Lloyd AG / Key word(s): 9 Month figures Hapag-Lloyd achieves good result in first three quarters of 2024 14.11.2024 / 07:29 CET/CEST The issuer is solely responsible for the content of this announcement. Hapag-Lloyd achieves good result in first three quarters of 2024 Year-on-year increase in transport volume Stronger demand and higher freight rate, particularly in the third quarter Earnings forecast raised in October Strategy 2030: Continued focus on growth and quality Hapag-Lloyd concluded the first nine months of 2024 with a Group EBITDA of USD 3....
Total number of shares and voting rights at October 31, 2024 12 November 2024 Orange: information on the total number of shares and voting rights referred to in Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. In application of Article L. 22-10-46 of the French Commercial Code (Code de commerce), as from 3 April 2016, a double voting right is automatically granted to fully paid-up shares that have been held in registered form and under a single shareholder name for at least two years. DateNumber of shar...
Nombre d'actions et de droits de vote au 31 octobre 2024 12 novembre 2024 Orange : Information relative au nombre total d’actions et de droits de vote prévue par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers En application de l’article L. 22-10-46 du Code de commerce, il est automatiquement conféré, à compter du 3 avril 2016, un droit de vote double aux actions entièrement libérées inscrites au nominatif depuis deux ans au nom d’un même actionnaire. DateNombre d’actions composant le capitalNombre d’actions auto-déte...
>Group’s adj. EBITDA significantly below expectations - At a group level, Bayer’s Q3 sales of € 9.97bn (-3.6%), were below our (€ 10.2bn) and consensus estimates (€ 10.1bn), the group’s EBITDA of € 1,251m (-26%) came in 9% weaker than we expected (€ 1,376m) and was 5% below the consensus (€ 1,313m). The significant group’s EBITDA decline vs Q3 2023 was driven by the Pharma division, which came in at € 1,102m (23.4% below Q3 2023). Adjusted EPS of € 0.24 was 37% below ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.